期刊文献+

3种药物分子的~1H和^(13)C NMR谱线全指定 被引量:9

~1H AND ^(13)C NMR CHEMICAL SHIFT ASSIGNMENT FOR THREE DRUGS
下载PDF
导出
摘要 应用 1D和 2DNMR技术 ,对 3种药物分子 :比卡鲁胺 (Bicalutamide)、马来酸罗格列酮(RosiglitazoneMaleate)、氯吡格雷硫酸盐 (ClopidogrelHydrogensulfate)的1 H和1 3CNMR的谱峰进行了准确归属 . The structures of bicalutamide, rosiglitazone maleate, clopidogrel hydrogensulfate were elucidated by 1D and 2D NMR spectroscopy. The ~1H and ^(13)C NMR chemical shifts of these compounds were assigned.
出处 《波谱学杂志》 CAS CSCD 北大核心 2004年第2期221-229,共9页 Chinese Journal of Magnetic Resonance
关键词 药物分析 核磁共振分析 马来酸罗格列酮 氯吡格雷硫酸盐 比卡鲁胺 NMR, assigaments, bicalutamide, rosiglitazone maleate, clopidogrel hydrogensulfate
  • 相关文献

参考文献7

  • 1Tucker H. Non-Steroidal Anti-androgens in the Treatment of Prostate Cancer [J]. Drugs Future, 1990, 15(3): 255-265.
  • 2Lunglmayr G. The International Casodex Study Group. Efficacy and toterability of Casodex in patients with advanced prostate cancer [J]. Anti-cancer Drugs, 1995, 6(4): 508-513.
  • 3Sorbera L A, Rabasseda X, Castaner J, et al. Rosiglitazone Maleate [J]. Drugs Future, 1998, 23(9):977.
  • 4Boneu B, Destelle G. Platelet anti-aggregating activity and tolerance of Clopidogrel in atherosclerotic patients[J]. Thombosis and Haemositasis, 1996, 76(6): 939-943.
  • 5Mills D C B, Puri R, Hu C J, et al. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase[J]. Arterioscler Thromb, 1992, 2: 430-436.
  • 6Salvi P, Heilmann E, Nurden P, et al. Clopidogrel: An antithrombotic drug acting on the ADP-dependent activation pathway of human platelets Clin[J]. Appl Thromb Haemost 1996, 2: 35-42.
  • 7Barrbie C Cantello, Michael A Cawthorne, Graham P Cottam, et al. [[ω-(Heterocyclylamino) alkoxy] benzyl]-2,4-thiozolidinediones as Potent Antihyperglycemic Agents [J]. Med Chem, 1994, 37(23): 3 977-3 985.

同被引文献52

引证文献9

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部